193 related articles for article (PubMed ID: 8310566)
1. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure].
Rud'ko IA; Kubatiev AA; Tsalenchuk IaP
Urol Nefrol (Mosk); 1993; (4):37-9. PubMed ID: 8310566
[TBL] [Abstract][Full Text] [Related]
2. Increased internal calcium mobilization in platelets of patients with chronic renal failure.
Tokumoto A; Uemasu J; Kawasaki H
Horm Metab Res; 1992 Dec; 24(12):588-92. PubMed ID: 1478620
[TBL] [Abstract][Full Text] [Related]
3. [Effect of hemodialysis on the cyclic nucleotide content of thrombocytes in patients with chronic kidney failure].
Rud'ko IA; Kulakov GP; Kubatiev AA
Urol Nefrol (Mosk); 1987; (5):47-50. PubMed ID: 3424469
[No Abstract] [Full Text] [Related]
4. [Influence of hemodialysis on expression of glycoprotein lb platelets reactivity in patients with the end stage renal failure].
Brzósko S; Hryszko T; Zak J; Wysocka J; Małyszko J; Myśliwiec M
Przegl Lek; 2002; 59(10):823-5. PubMed ID: 12632921
[TBL] [Abstract][Full Text] [Related]
5. Platelet function in chronic renal failure.
Bloom AL; Evans EP; Branch RA
Acta Univ Carol Med Monogr; 1972; 53():333-8. PubMed ID: 4670739
[No Abstract] [Full Text] [Related]
6. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
[TBL] [Abstract][Full Text] [Related]
7. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level.
Samal AB; Loiko EN
Biochemistry (Mosc); 2000 Feb; 65(2):230-6. PubMed ID: 10713553
[TBL] [Abstract][Full Text] [Related]
8. [Local microviscosity of platelet membranes from patients with chronic renal failure on hemodialysis].
Rud'ko IA; Chebotarev VN; Kubatiev AA
Patol Fiziol Eksp Ter; 1994; (1):20-2. PubMed ID: 8183585
[TBL] [Abstract][Full Text] [Related]
9. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
[TBL] [Abstract][Full Text] [Related]
10. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.
Grafnetterová J; Vodrázka Z; Jandová D; Schück O; Tomásek R; Lachmanová J
Clin Nephrol; 1976 Oct; 6(4):448-50. PubMed ID: 975643
[TBL] [Abstract][Full Text] [Related]
11. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.
Lages B; Weiss HJ
Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. [On dialysis therapy of chronic kidney failure].
Alwall N
Z Gesamte Inn Med; 1966 Sep; 21(18):Suppl:236-40. PubMed ID: 5990731
[No Abstract] [Full Text] [Related]
14. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
15. What influences the level of oxidative stress as measured by 8-hydroxy-2'-deoxyguanosine in patients on hemodialysis?
Mastalerz-Migas A; Steciwko A; Pokorski M; Pirogowicz I; Drobnik J; Bunio A; Muszyńska A; Jasińska A
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():199-205. PubMed ID: 17072047
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of ampicillin in patients with kidney allograft].
Iarmolinskii IS; Vasina TA; Goriainov VA
Antibiotiki; 1971 Jul; 16(7):661-3. PubMed ID: 4945581
[No Abstract] [Full Text] [Related]
17. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
Ershova LI; Gorbunova NA
Ter Arkh; 1997; 69(7):46-50. PubMed ID: 9424758
[TBL] [Abstract][Full Text] [Related]
18. [Hemodialysis treatment of chronic renal insufficiency].
Terekhov NT; Grechinskaia DA
Vrach Delo; 1973 May; 5():81-4. PubMed ID: 4757745
[No Abstract] [Full Text] [Related]
19. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
